During COVID-19, the Office of Sponsored Programs (OSP) plans to be fully operational.
The Office of Sponsored Programs (OSP) is currently fully operational. In response to the COVID-19 Pandemic, OSP will be working from home beginning March 16, 2020 until further notice. OSP staff continue to be available by email and phone, and our main line (412-624-7400) can also be used. Transaction requests and their related communications should continue to be sent through OSP electronic systems (MyFunding, MyRA, Contraxx, etc.)
For the latest updates from PittResearch, visit https://research.pitt.edu/pitt-researchers/research-operations-during-covid-19-pandemic. For all updates related to the University’s response to the COVID-19 pandemic, please visit www.emergency.pitt.edu/covid-19.
This page was last updated 04/14/2021 5:00 PM
OSP is monitoring the release of information related to COVID-19 from the University of Pittsburgh and from funding sponsors, including federal agencies. The information below will continue to be updated.
OSP Communications
E-mail regarding COVID-19 Information (released 03-12-2020)
Pitt Research
Senior Vice Chancellor for Research Update on Research at Pitt (12-14-2020)
Office of Research Protections Important Update on Tier 3 Studies (11-24-2020)
Senior Vice Chancellor for Research Update on Tier 3 Research Activities (11-23-2020)
Senior Vice Chancellor for Research Updated Details, Resources for Research Operations During the Pandemic (10-20-2020)
Senior Vice Chancellor for Research Research Restart website (06-10-2020)
Senior Vice Chancellor for Research Research Restart announcement (06-03-2020)
Senior Vice Chancellor for Research Guidelines for Essential Research Personnel (released 03-25-2020)
Senior Vice Chancellor for Research Coordination of COVID-19 Research at Pitt and UPMC (released 03-23-2020)
Senior Vice Chancellor for Research COVID-19: Status of Clinical Research Operations at Pitt (released 03-16-2020)
Senior Vice Chancellor for Research Pandemic Preparedness Guide for Researchers (released 03-12-2020)
Senior Vice Chancellor for Research Important - Clinical Research operations and COVID-19 (released 03-11-2020)
Senior Vice Chancellor for Research Emergency Page (released 03-11-2020)
Senior Vice Chancellor for Research COVID-19: Status of Research Operations at Pitt (released 03-11-2020)
University of Pittsburgh
Office of the Chancellor Our plans for being safe on campus (released 06-20-2020)
COVID-19 Update, confirmed case of coronavirus on campus (released 03-22-2020)
Office of Human Resources COVID-19 Workplace Concerns: Resources for Employees (released 03-18-2020)
Office of the Chancellor A Reduction in Operating Status (released 03-18-2020)
Office of the Chancellor COVID-19 update for faculty and staff (released 03-14-2020)
Office of the Chancellor COVID-19 Pandemic: Pitt's Actions (released 03-10-2020)
Pitt OHR Information Regarding Travel Expense Reimbursement and COVID-19 (released 03-10-2020)
Public Safety & Emergency Management’s COVID-19 information page (released 03-10-2020)
Pitt IT's Covid-19 Preparation Information (released 03-10-2020)
External Agencies
- NIH
- Notice of Clarification of Research Priorities for RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)" (NOT-AA-21-009) National Institute on Alcohol Abuse and Alcoholism (released 3-23-2021)
- Notice of Clarification of Research Priorities for RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)" (NOT-AA-21-010) National Institute on Alcohol Abuse and Alcoholism (released 3-23-2021)
- Notice of Clarification of Research Priorities for RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)" National Institute on Alcohol Abuse and Alcoholism (released 3-23-2021)
- Extramural News: Open Mike "Check Out NIH’s New COVID-19 Research Website" (released 1-19-2021)
- Extramural Nexus: Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic (released 12-01-2020)
- NOT-OD-21-026 Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic (released 11-06-2020)
- NOT-HS-21-002 AHRQ Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (released 11-06-2020)
- NOT-OD-21-018 Request for Information (RFI): Inviting Comments and Suggestions on the NIH-Wide Strategic Plan for COVID-19 Research (released 10-28-2020)
- NOT-OD-21-006 Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (released 10-23-2020)
- NOT-OD-20-164 Policy for Charging Personal Protective Equipment to NIH Grants and Cooperative Agreements as Direct Costs (released 09-11-2020)
- NOT-OD-20-163 Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic (released 08-14-2020)
- NOT-OD-20-158 Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic (released 08-14-2020)
- NOT-GM-20-042 Notice to Reduce the Number of Research Projects Required in PAR-19-313 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)" (released 07-21-2020)
- NOT-GM-20-043 Notice to Reduce the Number of Research Projects Required in PAR-19-312 "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)" (released 07-21-2020)
- NOT-OD-20-122 Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic (released 07-08-2020)
- Many New and Updated COVID-19 FAQs (released 07-02-2020)
- Will NIH Accept Late Applications for New Awards From Applicants Affected by COVID-19? (released 06-16-2020)
- Extramural Nexus regarding Requirement for Electronic Submission of All Administrative Supplements (released 06-30-2020)
- NOT-OD-20-123 Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic (released 06-12-2020)
- Open Mike: Emerging Research Now Available Through New NIH Preprint Pilot (released 06-09-2020)
- Open Mike: Accepting Preliminary Data as Post-Submission Material and Other COVID-19-Related Application Flexibilities (released 06-09-2020)
- Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency (released 06-10-2020)
- Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic (released 06-10-2020)
- NIAID Replaces COVID-19 NOSI for R03, Small Business Applications (released 05-20-2020)
- NOT-AG-20-033 NIA Late Application Policy for NIA-Specific FOAs with Application Due Dates in May, June, and July 2020 (released 05-17-2020)
- NOT-DE-20-025 NIDCR Announces Availability of Frequently Asked Questions (FAQs) for Coronavirus Disease 2019 (COVID-19)-Related Notices of Special Interest (NOSI) NOT-DE-20-022 and NOT-DE-20-023 (released 05-17-2020)
- NOT-GM-20-033 Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19)-Related Patient Outcomes (released 05-15-2020)
- NOT-CA-20-065 Request for Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences (released 05-14-2020)
- NOT-OD-20-105 NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19) (released 05-11-2020)
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding (Updated) (05-06-2020)
- Nora’s Blog (The Blog of the Director of the National Institute on Drug Abuse, NIDA) (released 04-06-2020)
- NOT-OD-20-091 UPDATE: NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) (released 03-26-2020)
- Open Mike Responding to Frequent Questions on Flexibilities Related to NIH Funding and COVID-19 (released 03-26-2020)
- NOT-AI-20-040 Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)," NOT-AI-20-030 (released 03-25-2020)
- Webinar on Pandemic Contingency Planning and Its Impact on Animal Care (released 03-19-2020)
- Information for Researchers Requesting SARS-CoV-2 from BEI Resources (released 03-18-2020)
- Video Message to Applicants and Recipients of NIH Funds on Flexibilities Needed for COVID-19 (released 03-17-2020)
- Pitt's summary of this video recording (released 03-19-2020)
- NOT-OD-20-088 Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19 (released 03-16-2020)
- NOT-OD-20-087 Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19 (released 03-16-2020)
- Open Mike COVID-19 Resources for Applicants and Recipients of NIH Funding (released 03-13-2020)
- NIH Guidance on Travel and Meetings (released 03-12-2020)
- NOT-OD-20-086 Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 (released 03-12-2020)
- NOT-OD-20-083 General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 (released 03-10-2020)
- COVID-19 Situation Summary page (released 03-10-2020)
- NOT-OD-20-082 NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) (released 03-09-2020)
- NIH Fogarty International Center Coronavirus news, funding, and resources for global health researchers
- NSF
- Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Panelists (07-20-2020)
- Frequently Asked Questions (FAQs) Relating to NSF’s Implementation of OMB Memorandum M-20-26 for NSF Proposers and Awardees (07-20-2020)
- NSF 20-100 Dear Colleague Letter: Supporting Research on Pandemics within the Civic Innovation Challenge and Broadened NSF Support for the Challenge (06-22-2020)
- Statement on NSF Proposal Deadlines (06-16-2020)
- NSF 20-095 Dear Colleague Letter: IUCRC Program Policy Flexibility in Response to the COVID-19 Pandemic Situation (released 06-09-2020)
- FAQs for Proposers and Awardees (05-05-2020)
- FAQs for Panelists (05-05-2020)
- Impact on Existing Deadline Dates (Updated 4-16-2020)
- FAQs for SBIR and STTR Grantees (Archived) (4-10-2020)
- NSF Implementation of OMB Memorandum M-20-20
- Extended Deadlines (04-03-2020)
- Revised FAQs for Proposers and Awardees (Archived) (04-02-2020)
- Revision of NSF’s Implementation of OMB Memorandum M-20-17: "Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations" (04-01-2020)
- FAQs for REU, RET, IRES Sites and Similar Activities (Archived) (03-31-2020)
- S-STEM Community Update (released 03-25-2020)
- Implementation of OMB Memo M-20-17: Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (released 03-23-2020)
- Letter to Community Regarding COVID-19 (released 03-23-2020)
- Impact on Existing Deadline Dates (released 03-17-2020)
- Detailed guidance on the Coronavirus website. (released 03-12-2020)
- OMB
- M-21-20 Promoting Public Trust in the Federal Government through Effective Implementation of the American Rescue Plan Act and Stewardship of the Taxpayer Resources (Released 03-30-2021)
- M-20-27 Additional Guidance on Federal Contracting Resiliency in the Fight Against the Coronavirus Disease (COVID-19) (released 07-14-2020)
- M-20-26 Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (released 06-18-2020)
- OMB Memo M-20-021 Implementation Guidance for Supplemental Funding in Response to COVID-19 Webinar (04-16-2020)
- NIDILRR Implementation of Flexibilities Under OMB Memo M-20-17 (released 03/31/2020)
- Managing Federal Contract Performance Issues Associated with the Novel Coronavirus (COVID-19) (released 03-20-2020)
- Memorandum M-20-17 Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (released 03-19-2020)
- Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) (released 03-09-2020)
- Other Federal Agencies
- ACL COVID-19 Response FAQ (released 03-20-2020)
- Acquisition.gov Federal Contracts: Coronavirus Acquisition-Related Information and Resources (released 03-24-2020)
- Administration for Children and Families (ACF) IM-ACF-OA-2020-02: Important Updates to Administrative Flexibilities identified in IM-ACF-OA-2020-01 (released on 07-24-2020)
- AHRQ NOT-HS-20-010 Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations
- Biomedical Advanced Research and Development Authority (BARDA)
- BAA-18-100-SOL-00003 Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) COVID-19 Due October 31, 2020 (released 08-19-2020)
- Amendment 19 – AOI #8.3 COVID-19 vaccine is suspended. White Paper and Full Proposal submissions under AOI #8.3 are suspended until further notice. All white papers or full proposals submitted to this area of interest will be considered automatically non-responsive. However, evaluation of vaccine development under Operation Warp Speed (OWS) program continues outside of BAA-18-100-SOL-00003. If promising candidates are identified, there is an opportunity for this area of interest to be reopened or for potential partnership with our colleagues at the Joint Program Executive Office (JPEO-CBRND).
- BAA-18-100-SOL-00003 Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) COVID-19 Due October 31, 2020 (released 08-19-2020)
- CDC
- Advisory Committee on Immunization Practices The meeting will be held on February 28, 2021-March 1, 2021, from 10:00 a.m. to 5:00 p.m. EDT (times subject to change). Written comments must be received on or before March 1, 2021 (released 02-25-2021)
- Advisory Committee on Immunization Practices (ACIP) Notice of meeting and request for comment. (released 09-21-2020)
- Advisory Committee on Immunization Practices The meeting will be held on September 22, 2020 from 10:00 a.m. to 4:00 p.m (released 08-14-2020),
- Updated CDC Flexibilities Guidance (released 07-10-2020)
- New Administrative Flexibilities Guidance for CDC Recipients affected by COVID-19 (released 04-21-2020)
- Coronavirus Disease 2019 (COVID-19) Information for CDC Applicants and Recipients of CDC Funding (released 03-27-2020)
- Centers for Medicare and Medicaid Services New and Expanded Flexibilities for Rural Health Clinics (RHCs) and Federal Qualified Health Centers (FQHCs) (released 4-17-2020)
- Department of Education
- HEERF Notice of Interpretation for Period of Allowable HEERF Expenses (March 19, 2021)
- HEERF Lost Revenue FAQs (March 19, 2021)
- HEERF Period of Allowable Expenses Grant Records Notice (March 19, 2021)
- New HEERF Guidance on expenses through the pandemic and calculating lost revenue (March 19, 2021)
- Department of Health and Human Services COVID-19 Health Equity Task Force Meeting (released 02-12-2021)
- DHS News Release: DHS Initiating Crucial Research to Mitigate COVID-19
- DOD
- The Air Force Office of Scientific Research Grant Guidance for Coronavirus Disease 2019 (COVID-19) (released 04-02-2020)
- USAMRAA COVID-19 FAQs for Grant Applicants and Recipients (released 03-25-2020)
- There are currently no plans to modify existing application deadline dates but please continue to monitor Grants.gov for any potential change(s) to an application deadline
- Frequently Asked Questions for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19) (released 03-24-2020)
- DARPA Frequently Asked Question (FAQ) about COVID-19 (Coronavirus) for DARPA Performers (released 03-19-2020)
- Department of the Airforce Potential Contract Impacts due to Coronavirus (COVID-19) (released 03-17-2020)
- DOE
- Memorandum for Office of Science Applicants and Awardees (released 09-30-2020)
- DOE Resources Supporting Coronavirus Research (released 04-30-2020)
- COVID-19: DOE Implementation of OMB Memorandum M-20-17 (released 04-14-2020)
- PF 2020-20 COVID-19 Guidance for Financial Assistance Actions (released 03-30-2020)
- COVID-19 Travel Guidance (released 03-23-2020)
- Dear Colleague Letter soliciting input to COVID-19 R&D response (released 03-13-2020)
- Accommodating Interruptions from Coronavirus Disease 2019 (COVID-19)(released 03-13-2020)
- DOJ
- OVW FAQs for Grantees Regarding the Payment and Use of Leave for Grant-Funded Staff (released 03-19-2020)
- OJP COVID-19 Impacts (released 03-16-2020)
- Solicitations with application due dates between March 16th and March 31st will have a 2-week extension for submission.
- EPA FAQs on Grant Issues in Response to COVID-19 (released 03-27-2020)
- FDA
- NOT-FD-20-019 Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19 (released 03-26-2020)
- Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic (released 03-19-2020)
- FEMA Coronavirus (COVID-19) Pandemic: Eligible Emergency Protective Measures (03-19-2020)
- HRSA
- Updated FAQ: Coronavirus Disease (COVID-19) Frequently Asked Questions – Federal Office of Rural Health Policy (updated 08-13-2020)
- Press Release: HHS Awards More than Half Billion Dollars Across the Nation to Expand COVID-19 Testing (05-08-2020)
- HRSA Temporarily Waving Query Fees for Health Care Entities to Search the National Practitioner Data Bank (NPDB) (released 04-21-2020)
- COVID-19 Grantee Frequently Asked Questions
- Novel Coronavirus (COVID-19) Frequently Asked Questions (released 03-19-2020)
- Institutes of Education Sciences (IES) Frequently Asked Questions (FAQs) About the Coronavirus Disease (COVID-19) for IES Grantees (released 04-17-2020)
- National Institute on Aging (NIA) NOT-AG-20-031 Frequently Asked Questions for NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (released 04-21-2020)
- NIAID Multi-Pronged Response to the COVID-2019 Outbreak (released 02-19-2020)
- National Institute of Mental Health (NIMH) NOT-MH-20-061 Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19)
- NASA Frequently Asked Questions about Grants and Research during the COVID-19 Epidemic (released 03-31-2020)
- NASA Virtual Town Hall 2020 (released 03-23-2020)
- NEA FAQs and Information for Applicants and Grantees in response to COVID-19 and Resources for Artists and Arts Organizations (released 03-18-2020)
- NEH
- Receives $75 Million to Distribute to Cultural Institutions Affected by Coronavirus (released 03-27-2020)
- FAQs – Funding for NEH Applicants and Grantees Impacted by the Coronavirus (released 03-13-2020)
- NSA
- GenCyber, update from the website: “Due to the impact of COVID-19 on school and academic institution calendars, the posting of scheduled 2020 GenCyber Camps may be delayed. We anticipate posting the final status and dates of each 2020 GenCyber Camp by May 20, 2020. If you have questions regarding a specific camp, please contact that institution but understand that a delay may occur in their response.”
- OTSI OSTI provides a custom search for Coronavirus and Related Biological Research Results and a list of search terms related to coronavirus research. (released 04-30-2019)
- PCORI Applicant and Awardee FAQs Related to COVID-19 (released 04-02-2020)
- SAMHSA
- SAMHSA Headlines: Dr. McCance-Katz Addresses the Cabinet on Mental Health Effects of COVID-19 (released 05-28-2020)
- COVID-19 Information for SAMHSA Discretionary Grant Recipients (released 03-24-2020)
- Science.gov A federated search that provides access to free journal articles, peer-reviewed accepted manuscripts, and reports of research funded by federal science agencies – has provided a custom search for Coronavirus Related Research. (released 04-30-2019)
- USAID
- COVID-19 Guidance for implementing partners (05-15-2020)
- COVID-19 Unsolicited Proposal/Application Progress (05-15-2020)
- LearningLab Monitoring, Evaluation and Learning during the COVID-19 Pandemic (05-15-2020)
- U.S. Department of Education
- Supplemental Frequently Asked Questions under Section 18004 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act (08-11-2020)
- Fiscal Operations Report for 2019–20 and Application to Participate for 2021–22 (FISAP) Reporting Instructions and Additional Flexibilities Under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) (08-03-2020)
- Agency Information Collection Activities; Comment Request; CARES Act 18004(a)(3) Budget and Expenditure Reporting comments due September 21, 2020 (07-22-2020)
- Additional Regulatory Flexibilities related to COVID-19 (07-10-2020)
- Supplemental FAQs for the CARES Act HEERF (06-17-2020)
- UPDATED Guidance for interruptions of study related to Coronavirus (COVID-19) (06-16-2020)
- CARES ACT Eligibility: Final Rule (06-17-2020)
- COVID-19 FAQs for Non-CARES Act Competitive Grant Programs Administered by the Office of Postsecondary Education (06-08-2020)
- FAQs from Students about the HEERF Student Grants
- Higher Education Emergency Relief Fund Reporting - Emergency Financial Aid Grants to Students (05-08-2020)
- Secretary Devos Announces $3 Billion in Emergency Education Block Grants for Governors (4-14-2020)
- Select Questions Related to Use of Department of Education Grant Funds During the Novel Coronavirus Disease 2019
- COVID-19 Information and Resources for Schools and School Personnel
- The Office of Postsecondary Education issued Guidance for interruptions of study related to Coronavirus (COVID-19)
- The Office of Postsecondary Education issued Information for Accrediting Agencies Regarding Temporary Flexibilities Provided to Coronavirus Impacted Institutions or Accrediting Agencies.
- U.S. Department of Health & Human Services HHS Begins Distribution of Payments to Hospitals with High COVID-19 Admissions, Rural Providers (05-08-2020)
- USDA
- NIFA-20-005 NIFA Coronavirus FAQs (07-22-2020)
- COVID-19 FAQs Webinar (04-17-2020)
- Distance Learning and Telemedicine Grant Program Webinar on 5/5 (04-17-2020)
- Updated NIFA Coronavirus FAQs (4/14/2020)
- Rural Development COVID-19 Response
- VA Contractor COVID-19 Guidance (released 03-12-2020)
- Other Agencies and Organizations
- Administration for Community Living Medicare Coverage Webinar (released 04-22-2020)
- AHA
- Research Insider – April 2020 Edition (released 04-07-2020)
- Notice to AHA Research Community Regarding COVID-19 (released 03-20-2020)
- Allegheny County DHS COVID-19 Updates for DHS Providers
- Candid Funds for Coronavirus Relief (released 04-06-2020)
- Consortium of Social Science Associations (COSSA) COSSA COVID-19 Pandemic Resources (4-16-2020)
- Council on Government Relations (COGR)
- Grants Plus Emergency Grant Opportunities (released 04-06-2020)
- PA Department of Community and Economic Development (DCED) COVID-19 Resources for Businesses, Communities, and Local Governments (07-16-2020)
- PA Department of Health (DOH) Interim Guidance for Department of Health Grantees on COVID-19 Response (released 03-16-2020)
- Small Business Administration
Funding Opportunities